Medicure (MCUJF) Current Deferred Tax Assets (2015 - 2016)
Medicure's (MCUJF) quarterly Current Deferred Tax Assets came in at $725774.0 in Q3 2016, little changed quarter-over-quarter from $725774.0 in Q4 2015.
Medicure (MCUJF) Current Deferred Tax Assets (2015 - 2016) Analysis & Trends
Medicure's Current Deferred Tax Assets history runs 2 years deep, the most recent figure standing at $725774.0 for Q3 2016.
- On a quarterly basis, Current Deferred Tax Assets changed N/A year-over-year to $725774.0 in Q3 2016; TTM through Sep 2016 was $725774.0, a N/A change from a year earlier, with the FY2015 full-year figure at $725774.0, changed N/A from the prior year.
- Current Deferred Tax Assets was little changed at $725774.0 in Q3 2016 per MCUJF's latest filing, from $725774.0 in the prior quarter.
- Across five years, Current Deferred Tax Assets topped out at $725774.0 in Q4 2015 and bottomed at $725774.0 in Q4 2015.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Medicure | 8.77 Mn | 7.64 Mn | 2.57 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2016 | 725,774.00 |
| Sep 30, 2016 | 725,774.00 |
| Dec 31, 2015 | 725,774.00 |
| Dec 31, 2015 | 725,774.00 |